Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?
Related Experiment Video
Updated: Jul 23, 2025

Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Nancy J Devlin1, Tianxin Pan2, Mark Sculpher3
1Health Economics Unit, Melbourne School of Population and Global Health, University of Melbourne, 207 Bouverie St, Melbourne, VIC, 3010, Australia. nancy.devlin@unimelb.edu.au.
Insights
Value sets for pediatric health (EQ-5D-Y-3L) differ from adult sets, potentially due to wording or respondent perspectives. Understanding these differences is crucial for accurate economic evaluations in healthcare resource allocation.
Area of Science:
- Health Economics
- Pediatric Quality of Life Measurement
- Psychometrics
Background:
- Value sets for the EQ-5D-Y-3L (child-specific instrument) show distinct characteristics compared to adult EQ-5D value sets.
- Key differences include higher values for the worst health states and fewer negative values in pediatric sets.
Purpose of the Study:
- To investigate the reasons behind the differences between child and adult health values.
- To explore the implications of these differences for using EQ-5D-Y-3L values in economic evaluations for healthcare resource allocation.
Main Methods:
- The study posits four potential explanations for observed value set differences.
- These include differences in descriptive severity, adult perceptions of child health, elicitation of preferences for others, and anchoring of 'dead=0' for child survival.
Main Results:
- Existing evidence does not exclude upward bias in values due to eliciting preferences for others or child survival considerations.
- These factors may influence the interpretation and application of pediatric health-related quality of life (HRQoL) values.
Conclusions:
- Differences in EQ-5D-Y-3L value sets compared to adult sets necessitate careful consideration in economic evaluations.
- Alternative, non-age-specific methods for valuing pediatric HRQoL may mitigate non-comparability issues.
- Health technology assessment bodies must address specific considerations for child quality-adjusted life-year gains.
Abstract:
Value sets for the EQ-5D-Y-3L published to date appear to have distinctive characteristics compared with value sets for corresponding adult instruments: in many cases, the value for the worst health state is higher and there are fewer values < 0. The aim of this paper is to consider how and why values for child and adult health differ; and what the implications of that are for the use of EQ-5D-Y-3L values in economic evaluations to inform healthcare resource allocation decisions. We posit four potential explanations for the differences in values: (a) The wording of severity labels may mean the worst problems on the EQ-5D-Y-3L are descriptively less severe than those on the EQ-5D-5L; (b) Adults may genuinely consider that children are less badly affected than adults by descriptively similar health issues. That is, for any given health problem, adult respondents in valuation studies consider children's overall health-related quality of life (HRQoL) on average to be higher than that for adults; (c) Values are being sought by eliciting adults' stated preferences for HRQoL in another person, rather than in themselves (regardless of whether the 'other person' concerned is a child); and (d) The need to elicit preferences for child HRQoL that are anchored at dead = 0 invokes special considerations regarding children's survival. Existing evidence does not rule out the possibility that (c) and (d) exert an upward bias in values. We consider the implications of that for the interpretation and use of values for pediatric HRQoL. Alternative methods for valuing children's HRQoL in a manner that is not 'age specific' are possible and may help to avoid issues of non-comparability. Use of these methods would place the onus on health technology assessment bodies to reflect any special considerations regarding child quality-adjusted life-year gains.
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Relative Risk

